| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CEO, Medical Segment | CEO, Pharmaceutical Segment
2 companies
Giacomin Jon L is a Director at ORGO with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $14.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2018 | CAH Cardinal Health Inc | CEO, Medical Segment | Sell | 2,890 | $51.95 | $150,135.50 | -3.8% | |
| Feb 20, 2018 | CAH Cardinal Health Inc | CEO, Medical Segment | Sell | 7,995 | $68.78 | $549,924.12 | -6.6% | |
| May 12, 2017 | CAH Cardinal Health Inc | CEO, Pharmaceutical Segment | Sale+OE | 23,270 | $72.87 | $1,695,684.90 | -42.0% | |
| Aug 16, 2016 | CAH Cardinal Health Inc | CEO, Pharmaceutical Segment | Sale+OE | 47,251 | $82.77 | $3,910,965.27 | -58.9% |